India.com News Desk | Jun 15, 2022, 10:52 PM IST
Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
India.com News Desk | May 3, 2022, 7:59 PM IST
According to the reports, children can get the vaccine at private centres with a provision for it being made on the CoWIN portal.
India.com News Desk | Apr 29, 2022, 5:32 PM IST
The Central Drugs Standard Control Organisation's Subject Expert Committee had approved the Serum Institute of India's Covovax for restricted use in emergency situations in adults on December 28. On March 9, it recommended granting the Emergency Use Authorisation for Covovax for the 12-17 age group.
India.com News Desk | Apr 22, 2022, 5:43 PM IST
Calling for increased adoption of booster doses, Poonawalla said it is also needed because people need to travel internally and outside, and many countries have made booster doses mandatory for travel.
India.com News Desk | Apr 9, 2022, 3:38 PM IST
On Friday, the company had said that the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.
India.com News Desk | Apr 9, 2022, 4:02 PM IST
We have decided to revise the price of Covaxin from Rs 1200 to Rs 225 per dose for private hospitals, Suchitra Ella, Joint Managing Director, Bharat Biotech said.
India.com News Desk | Apr 8, 2022, 5:51 PM IST
Giving details, Adar Poonawala said the Serum Institute will offer large discounts to hospitals and distributors who like to offer booster doses.
India.com News Desk | Apr 5, 2022, 2:15 PM IST
Adar Poonawalla asserted that SII has enough stock for the rollout of booster doses. Referring to the other countries that are administering booster doses, Poonawala further said that it's time for India also to look at it.
India.com News Desk | Apr 4, 2022, 7:13 PM IST
When asked whether the vaccines in their current form work on new coronavirus variants, Poonawalla said they will work only if a booster dose is taken, as this will form protection from future variants.
India.com Business Desk | Mar 16, 2022, 6:26 PM IST
Cyrus Poonawalla Net Worth: The 'Vaccine King' registered a growth of 41 per cent in this net worth in 2021 and is the fourth richest individual in India. Cyrus Poonawalla's net worth, at present, is $26 billion.
India.com News Desk | Mar 9, 2022, 5:48 PM IST
The approval from Drugs Controller General Of India's (DCGI) comes after the Subject Expert Committee on COVID-19 of the CDSCO last week recommended granting emergency use authorisation (EUA) to Covovax for those aged 12 to 17.
India.com News Desk | Mar 4, 2022, 10:10 PM IST
The Drugs Controller General of India (DCGI) had approved Covovax for restricted emergency use in adults on December 28.
English
